Definitive Contract 75F40119C10120
Award Date 9/12/19
Potential Completion Date 6/16/22
Potential Value $210K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Horsham, PA 19044, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the SAFEMED USE program, which provides access to medication error data, products, and services. The contract, awarded to the Institute for Safe Medication Practices (ISMP), a non-profit organization, has a ceiling value of $3,235,495.83 and a completion date of September 29, 2030. The contract is a firm fixed-price purchase order, funded by the Food and Drug Administration (FDA), a civilian agency. ISMP has secured multiple prime federal contracts from...
- This is a federal contract awarded by the Food and Drug Administration (FDA) to the American Society of Health-System Pharmacists (ASHP), a non-profit organization that serves as the primary accrediting body for pharmacy residency programs in the U.S. The contract, titled "National Standardization of IV and Oral Liquid Medications," has a ceiling value of $513,963.79 and an ultimate completion date of September 29, 2020. This is a definitive contract with a cost-no-fee pricing type and...
- This $291,142 firm fixed price prime contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the Institute For Clinical Pharmacodynamics, Inc. to conduct research on updating susceptibility guidance for the oral antibiotics sulfamethoxazole-trimethoprim. The contract supports the agency's efforts to develop modernized susceptibility guidance using pharmacometric approaches. No set-aside designation was used for this award. The Institute For Clinical...
- The Department of Health and Human Services Food and Drug Administration awarded a $1.91 million firm fixed price definitive contract to Information Systems Audit And Control Association, Inc. doing business as Isaca. Under the contract, Isaca will provide the CASE FOR QUALITY Voluntary Improvement Program and Medical Device Analysis - CMMI Enterprise Access and MDDAP Training Enhancement. Specifically, Isaca will deliver the CASE FOR QUALITY program and related medical device analysis...
- This contract was awarded by the U.S. Department of Health and Human Services (HHS) to an unspecified prime contractor for an assessment of the United States' drug safety system to be conducted by the National Academies of Sciences (NAS) and the Institute of Medicine (IOM). The total potential value of this delivery order contract is $49,000.00, and it does not have a set-aside designation. The contract was awarded on April 1, 2005 and has a final completion date of May 15, 2006. The place of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $97,266 firm fixed price blanket purchase agreement call contract to the Institute For Safe Medication Practices to provide an acute care newsletter subscription from April 1, 2022 through March 31, 2023. The Institute For Safe Medication Practices, located in Plymouth Meeting, Pennsylvania, will deliver its acute care newsletter to support the Department of Veterans Affairs'...
- This federal contract award was made by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to The United States Pharmacopeial Convention, Inc. (USP), an independent, non-profit organization that sets standards for medicines, food ingredients, and dietary supplements. The $97,265.00 firm fixed-price purchase order contract is for USP to provide web-based platforms and online access to the United States Pharmacopeia National...
- The Food and Drug Administration awarded a firm fixed-price purchase order to The International Society of Pharmacometrics, Inc. (UEI: MDVRKXEUXQH5) in the amount of $48,280.00 on September 26, 2025. This contract represents the ratification of an unauthorized commitment for a public workshop held on November 9, 2023, in Forest Heights, Maryland. The award was made without a set-aside designation and carries a ceiling value equal to the contract amount, with an ultimate completion date of...
- This $291,618 definitive contract was awarded by the Food and Drug Administration (FDA) to the Institute For Clinical Pharmacodynamics, Inc. (ICPI), a for-profit, minority-owned organization. The contract is in support of the FDA's Combatting Antibiotic Resistant Bacteria (CARB) program and will have a period of performance through September 29, 2023. Under this contract, ICPI will provide pharmacometric analysis and modeling services to the FDA to support updating clinical breakpoints for the...
- The U.S. Food and Drug Administration (FDA) awarded a $80,666.00 firm fixed-price purchase order contract to the American Society of Health-System Pharmacists Inc. (ASHP), a non-profit organization, to provide access to the AHFS Pharmacologic-Therapeutic Classification System data for the FDA Center for Drug Evaluation and Research (CDER). This contract has an ultimate completion date of September 15, 2024. ASHP is the sole provider of these specialized accreditation services for federal...
The Department of Health and Human Services Food and Drug Administration awarded a definitive contract to the Institute for Safe Medication Practices, a 501(c)(3) nonprofit organization. The $209,738.72 contract, which was not set aside, is for the delivery of a Perioperative Medication Safety Self-Assessment for Hospitals and Ambulatory Surgical Centers (ASCs) and Targeted Risk-Reduction Tool Development. Through past prime federal contracts, the Institute for Safe Medication Practices has provided services to reduce medication errors and improve patient safety for agencies such as the Department of Veterans Affairs and Defense Health Agency. The contract is a cost-no-fee pricing type and has a completion date of June 16, 2022.
Generated 3/24/24, 3:09 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science | FDABAA-19-00123 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 1/1 | 10/18/18, 9:54 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Close Out | ($918) | 4/12/23 | |
| P00001 | Other Administrative Action | $0 | 5/4/21 | |
| Not listed | Not listed | $210.7k | 9/12/19 |